Carleton B Davis, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000 |
James C Pollock, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000 |
Mr. Wissam E. Mattar, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe Clinic And Hospitals, Monroe, WI 53566 Phone: 608-324-2278 |
News Archive
Kensey Nash Corporation, a regenerative medicine company, today announced that it entered into a new two-year Supply Agreement with St. Jude Medical, Inc. for the period from January 1, 2011 to December 31, 2012. The agreement provides for Kensey Nash to be the exclusive outside supplier of collagen plugs, one of the key resorbable components of the Angio-Seal Vascular Closure Device, the leading arterial puncture closure product in the world.
Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.
Differences in the levels of two key metabolic enzymes may explain why some people are more susceptible to liver damage, according to a study in the October 17 issue of The Journal of Cell Biology (www.jcb.org).
Cell Therapeutics, Inc. today announced that it has been awarded $977,917 in grants under the Therapeutic Discovery Tax Credit program that was enacted under the U.S. government's Patient Protection and Affordable Care Act. The program targets projects that show potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer.
In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the University of California, San Diego (UCSD) School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.
› Verified 5 days ago